Search

everythinglearnresearchcommunity

for

Search:↓

Myristoleic acid helps hair growth by boosting cell growth and recycling processes in hair follicle cells.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Hair loss caused by genetics and hormones; more research needed for treatments.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

DNMT1 helps turn hair follicle stem cells into fat cells by blocking a specific microRNA.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Kojyl cinnamate ester derivatives can promote hair growth by increasing adiponectin production in fat tissues.

Skin changes in women with PCOS are mainly due to hormonal imbalances.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

More precise, personalized therapies are needed for autoimmune diseases.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

People with polycystic ovary syndrome are more likely to have poor sleep, restless legs syndrome, anxiety, and depression.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

The document concludes that a deeper understanding of skin aging and photodamage is needed to create better skin treatments.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Fat tissue and a specific protein are crucial for healthy hair growth and maintenance.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Alopecia Areata might be linked to Crohn's disease.